Home > News
|
Clinical Trials Update: July 30, 2004 |
|
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Bipolar Disorders
A research study of an investigational medication for the treatment of bipolar disorder. Volunteers 18 and older who have been diagnosed with bipolar I disorder may be eligible. Research site located in Glendale, Calif.
More Information
Please see http://www.centerwatch.com/patient/studies/cat20.html.
-----
Leukemia
A research study to investigate whether patients with acute myeloid leukemia (AML) age 60 and older are able to take higher doses of a chemotherapy regimen Idarubicin, which is typically given at lower doses. Volunteers who have been newly diagnosed with AML and who have adequate liver, kidney, and heart function may be eligible. Research site located in Kansas City, Kan.
More Information
Please see http://www.centerwatch.com/patient/studies/cat92.html.
-----
Multiple Sclerosis
A research study to compare the effectiveness of three FDA-approved drugs to treat multiple sclerosis (MS). Volunteers ages 18 to 45 who have been diagnosed with relapsing/remitting MS and have been taking either Rebif or Betaseron for at least one year may be eligible. Research site located in Plantation, Fla.
More Information
Please see http://www.centerwatch.com/patient/studies/cat102.html.
-----
Copyright 2004 CenterWatch. All rights reserved.
Copyright © 2004 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder® does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder® health library.
